Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

185

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01XG03	NINLARO	B	Ixazomib - 4mg	4mg	Capsule, hard	388,991,058 L.L
S02AA15	SEPTOCIPRO OTICO	B	Ciprofloxacine (HCl) - 1mg/0.5ml	1mg/0.5ml	Solution	473,033 L.L
A04AD	GRAVOL	B	Dimenhydrinate - 50mg	50mg	Tablet	163,949 L.L
C01EB15	VASTAREL	B	Trimetazidine - 35mg	35mg	Tablet, film coated, modified release	1,053,573 L.L
L01CX01	YONDELIS	B	Trabectedin - 1mg	1mg	Injectable powder for solution	126,536,515 L.L
L01XG03	NINLARO	B	Ixazomib - 3mg	3mg	Capsule, hard	348,420,676 L.L
M05BA06	BONDRONAT	B	Ibandronic acid (monosodium monohydrate) - 6mg/6ml	6mg/6ml	Injectable concentrated powder for solution	24,963,868 L.L
A04AD	GRAVOL	B	Dimenhydrinate - 100mg	100mg	Suppository	294,302 L.L
C09AA05	TRITACE	B	Ramipril - 5mg	5mg	Tablet	509,316 L.L
D06BA51	IALUGEN PLUS	B	Silver sulfadiazine - 10mg/g, Sodium hyaluronate - 2mg/g		Cream	1,064,323 L.L
J01DI01	ZEVTERA	B	Ceftobiprole medocaril Sodium - 500mg	500mg	Injectable powder for concentrate for solution	47,129,773 L.L
L01XG03	NINLARO	B	Ixazomib - 2.3mg	2.3mg	Capsule, hard	272,619,919 L.L
M05BA06	BONVIVA	B	Ibandronic acid - 3mg/3ml	3mg/3ml	Injectable solution	3,144,591 L.L
R05CB06	MUCOSOLVAN	B	Ambroxol HCl - 30mg/5ml	30mg/5ml	Syrup	380,307 L.L
S02AA30	TYOTOCIN	B	Hexylresorcinol - 0.1%, Antipyrine - 5%, Benzocaine - 1.25%, Tyrothricin - 0.05%		Drops solution	409,552 L.L
C01EB17	PROCORALAN	B	Ivabradin (HCl) - 5mg	5mg	Tablet, film coated	1,890,786 L.L
L01XJ01	ERIVEDGE	B	Vismodegib - 150mg	150mg	Capsule	465,368,012 L.L
A10BD15	XIGDUO XR	B	Metformin HCl XR - 1000mg, Dapagliflozin - 10mg		Tablet	3,006,579 L.L
B01AE07	PRADAXA	B	Dabigatran etexilate (mesilate) - 110mg	110mg	Capsule, hard	1,603,204 L.L
D06BA51	IALUGEN PLUS	B	Silver sulfadiazine - 10mg/g, Sodium hyaluronate - 0.5mg/g		Gauze	1,463,444 L.L
J01DI54	ZERBAXA	B	Ceftolozane Sulfate - 1g, Tazobactam (sodium) - 0.5g		Injectable powder for concentrate for solution	74,780,802 L.L
L01XK01	LYNPARZA	B	Olaparib - 100mg	100mg	Tablet, film coated	230,789,350 L.L
L04AX06	IMNOVID	B	Pomalidomide - 2mg	2mg	Capsule, hard	407,188,707 L.L
N02CC04	MAXALT	B	Rizatriptan (benzoate) - 10mg		Tablet	439,436 L.L
S02CA02	VIOCORTENE	B	Clioquinol - 10mg/ml, Flumetasone pivalate - 0.2mg/ml		Drops	568,253 L.L
A05AA02	URSOFALK	B	Ursodeoxycholic acid - 250mg	250mg	Capsule	2,823,413 L.L
B01AE07	PRADAXA	B	Dabigatran etexilate (mesilate) - 110mg	110mg	Capsule, hard	3,205,064 L.L
L01XK01	LYNPARZA	B	Olaparib - 150mg	150mg	Tablet, film coated	230,789,350 L.L
L04AX06	IMNOVID	B	Pomalidomide - 4mg	4mg	Capsule, hard	417,741,356 L.L
A05AA04	OCALIVA	B	Obeticholic acid - 10mg	10mg	Tablet, film coated	224,503,943 L.L

...

185